Celyad to Present at Cowen and Company 37th Annual Health Care Conference – Yahoo Finance
|
Celyad to Present at Cowen and Company 37th Annual Health Care Conference
Yahoo Finance The Company utilizes its expertise in cell engineering to target cancer. Celyad's Natural Killer Receptor based T–Cell (NKR-T) platform has the potential to treat a broad range of solid and hematologic tumors. Its lead oncology candidate, the CAR-T NKR … |
